An orphan in Victorian England falls in with a gang of pickpockets, led by the Artful Dodger and under the direction of ...

Orphan 3 star Isabelle Fuhrman has shared some exciting new details about the upcoming horror sequel. The film follows 2022’s Orphan: First Kill, a prequel to 2009’s Orphan. In both titles, Fuhrman ...

The true cost of the immigration policy can be measured in the generations of Chinese Americans who were never born.

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).

A third installment in the Orphan horror film series is currently in the works at Lionsgate. Isabella Fuhrman, who played the psychopathic Esther in the first two movies, recently offered some insight ...

The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome ...

An orphan in Victorian England falls in with a gang of pickpockets, led by the Artful Dodger and under the direction of ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

Years after becoming a horror icon as a child, the industry may not have thought of Fuhrman as a romantic lead. But, as she ...